产品名称 | lifastuzumab vedotin |
---|
CAS编号和信息 | Ab175578 |
---|
Wikipedia | Lifastuzumab vedotin |
---|---|
IMGT/mAb-DB | 478 |
Target ID | 1136 | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
名称 | Sodium phosphate 2 | ||||||||||||||||||||||||
缩写名 | NaPi-IIb | ||||||||||||||||||||||||
家族 | SLC34 family of sodium phosphate co-transporters | ||||||||||||||||||||||||
别名 | glucocorticoid-induced receptor | ||||||||||||||||||||||||
基因和蛋白信息 |
|
||||||||||||||||||||||||
Ensembl Gene | ENSG00000157765 (Hs) , ENSMUSG00000029188 (Mm) , ENSRNOG00000004626 (Rn) | ||||||||||||||||||||||||
Entrez Gene | 20531 (Mm) , 84395 (Rn) , 10568 (Hs) | ||||||||||||||||||||||||
OMIM | 604217 (Hs) | ||||||||||||||||||||||||
Protein GI | 295789160 (Hs) , 16758110 (Rn) , 66793411 (Mm) | ||||||||||||||||||||||||
UniProtKB | O95436 (Hs) , Q9DBP0 (Mm) , Q9JJ09 (Rn) | ||||||||||||||||||||||||
Bioparadigms SLC Tables | SLC34A2 (Hs) | ||||||||||||||||||||||||
RESOLUTE | SLC34A2 (Hs) | ||||||||||||||||||||||||
ChEMBL Target | CHEMBL4295685 (Hs) |
Ligand ID | 8405 |
---|---|
名称 | lifastuzumab vedotin |
别名 | DNIB0600A |
类别 | Antibody |
学名 | 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide |
生物活性评价 |
Patent US8535675 |
评价 |
Lifastuzumab vedotin is an antibody drug conjugate containing an anti-SLC34A2 (sodium phosphate 2 transporter) monoclonal antibody linked to the toxin monomethyl auristatin E (MMAE, aka vedotin; PubChem CID 11542188). Peptide sequence information for this antibody is available from its IMGT/mAb-DB record. Peptide sequence match identifies US8535675 as the covering patent |
单字母多肽序列 | |
三字母多肽序列 | |
翻译后修饰 | |
化学修饰 |